Abstract
INTRODUCTION
T h e accidental discovery of the Australia antigen ('HAA) in 19 6 3 by B lu m berg and his coworkers is a classical exam ple o f biom edical serendipity. Its recognition not only stim u lated a substantial am ount of research into viral hepatitis, thereby adding considerably to our knowledge about this im portant disease, bu t has had far-reaching im plications in the understanding o f several other h epatic and system ic diseases.
In deed, its discovery m ay well be seen in the future to have been the all-im portant breakthrough in attem pts at culture o f the virus as a m eans of vaccine prepartion fo r future prophylactic usage.
THE DISCOVERY OF THE ANTIGEN
B lum berg, a cytogeneticist w orking in the Philadelphia In stitute fo r C an cer R esearch, was conducting a system atic study o f the serum o f patients w ho had received m ultiple blood transfusions. U sin g a technique of double diffusion in agar gel (O uchterlony m ethod) he searched fo r precipitating anti bodies to inherited donor serum protein anti gens, particularly those to low density betalipoproteins.
A precipitating an tibod y was identified in th e serum of a h aem ophiliac p atient which reacted w ith an antigen which was quite dissim ilar from lipoprotein antigens. T h is antigen was present in the serum of an A ustralian aborigine, and the term Australia antigen was coined ( 1, 2, 3,) .
T h is antigen is alm ost certainly identical to P rin ce's SHantigen (4) , and to avoid confusion the term hepatitis-associated antigen (H A A ) is now con sidered b y m any to b e m ore appropriate (5) .
It was som e tim e before it becam e apparent that the A ustralia antigen was closely related to, or m ight be located directly on, a hepa titis virus.
It was found in the serum o f som e 30 per cent o f patients institutionalised be cause o f D o w n 's syndrom e (m ongolism ) but did not occur in out-patients w ith this disease or in hospitalised patients w ith other causes o f m ental retardation.
In these institutional ised m ongoloid patients antigenaem ia was associated w ith chronic anicteric h epatitis, as shown by liver biopsy and elevated S .G .P .T . levels (6) .
T h e antigen was isolated by density-gradient sedim entation, and under the electron m icroscope was found to be a particle of 200 A° in diam eter w ith knob-like subunits of som e 30 A° on the surface.
A gglutination o f these particles occurred on addition o f anti-H A A antiserum .
T h e liver cells o f patients w hose blood contained the antigen was then shown to have striking fluorescent granules in or on th eir nuclei when fluorescent an ti-H A A was added (7), a phenom enon n o t seen in patients w ith ou t h epatitis or in those w ho do not have th e antigen in their blood (3) . C lin ical hepatitis was then found to result in a high proportion o f patients given transfusions of blood from donors who carried the Australia antigen (8) .
E pid em iological studies sugges ted that the antigen was an infective agent, and supported the conclusion th at the Austrailia antigen was in tim ately associated with a virus that caused hepatitis. Subsequent studies suggested th at th e antigen was associated w ith clinically d ifferent form s o f h epatitis, the form d epending on the im m u ne status o f the p atient (9) .
T h e antigen was also shown to b e rare in N o rth A m erica and th e U n ite d K in g d o m (0.1 per cen t) b u t was c o m m on in p eo p le livin g in th e tropics (2-20 per cen t). In d eed , th ese p atien ts seem ed to be su scep tib le to ch ro n ic in fe ctio n w ith th e h ep a titis virus (10), a p o in t th a t w ill b e m ore fu lly discussed later.
THE NATURE OF THE ANTIGEN
T h e A u stra lia a n tigen w as show n b y th e B lu m b e rg gro u p to d iffer from the serum betalip op rotein s w h ich th e y had p revio u sly de scribed in th a t it h a d a high m o lecu la r w eigh t and co n ta in ed p rotein s w ith m in im a l am o u n ts o f lip id . E lec tro n m icro sco p ic studies o f antigen -positive serum , prepared b y sucrose density-gradien t ce n trifu g atio n and a negativestain in g tech n iq u e , revealed virus-like particles S o m e had a central core w h ile others w ere elo n ga ted th e ir le n g th varyin g from 500 A° to 2 300 A°.
T h e a d d ition o f sp ecific rab b it antiserum to the A ustralia an tigen resulted in a gglu tin a tio n o f the particles.
T h e un usual degree o f pleom orp h ism w as th e o n ly feature in co m p a tib le w ith firm a ccep ta n ce o f th e particles as viral in o rigin.
N u c le ic acid has, h o w ever, never been d em o n strated in th ese particles, a n o th er so m ew h a t un usual featu re, a lth o u gh it is pos sible th a t the virus co n ta in s little or no n u cleic acid.
A w id e variety o f particles can b e d e tecte d in serum b y electro n m icrosco p y and A ustralia an tigen p articles are so p leo m o r p h ic th a t th e y m a y o n ly b e recognised w ith co n fid en ce in th e p resen ce o f tu b u lar form s (12) .
Sm all an tigen p articles seem to pre d o m in ate in a cu te h e p atitis, w h ile large par ticles and tu b u la r form s o ccu r in carriers o f the an tigen , or in p atien ts w ith ch ro n ic h e p a titis.
C e rta in ly , th ere is n o w w id e a ccep tan ce th a t th e p resen ce o f particles o f 22 A 0, w ith little su bstru ctu re, and th ose o f 42 A° w ith a dense o u ter co a t a b o u t 7 A° across and an in n er b o d y o f 28 A 0 in association w ith H A A . is in d icativ e o f in fe ctio n w ith th e S .H . virus. S in ce the sp ecific a n tib o d y to A ustralia a n ti pen w ill cause clu m p in g o f b o th these p arti cles (13) it is n ow gen erally agreed th at th e a r ticles th em selves co n stitu te the an tigen ) 14) .
A lm eid a and W a te rso n (13) h a ve described th ree p a tte rns o f A ustralia antigen as observed un der th e electron m icro sco p e in relation to clin ical features.
1. In th e p a tie n t w ith fu lm in a n t h e p atitis, large a m o u n ts o f a n tib o d y separate the aggregated particles;
2. in th e p atie n t w ith ch ro n ic active h ep atitis, u n atta ch ed p articles o f antigenw ere seen, to g e th er w ith im m u n e co m plexes w ith antigen excess; and 3. in sym p to m -free carriers o f the an tigen , ran d o m ly distrib u ted sp herical and tu b u lar p articles w ere observed w ith o u t c lu m p in g b y a n tib o d y . It has been suggested b y D a n e et al ( 19 70) that th e large (42 A°) p a rticles are th e virus itself, w h ile th e tu b u lar form s are surplus virus co ated m aterial (15) .
T h e s e p articles h ave so m e features in co m m o n w ith arborviruses. It has, h o w ever, been variou sly suggested th at th e virus associated w ith the A ustralia an tigen m ay b e a varian t o f th e co w p ea-ch lo ro tic virus, o r a m e m b er o f th e p ico m aviru s fam ily, w h ich cause d u ck h ep atitis.
A lm eid a and h er co l leagues h a ve fu rth e r suggested th at th e A u s tralia an tigen m ay b e an aggregation o f p rotein subun its derived from th e virus (13, 16) . Z u ckerm an, w o rk in g w ith A lm eid a , has described particles fo u n d on electro n m icrosco p y th a t dis played th e characteristics o f th e coronavirus group , and suggested th a t th e particles appeared to co n sist o f a n tigen -an tib od y Com plexes (17 , 18) .
M o r e rece n tly this group h ave reported th e ap p aren tly successful p ro pagation o f th e serum h e p atitis virus in hu m an em b ryo live r organ cultures, co n firm in g th e ir results on electro n m icrosco p y.
M a te ria l harvested from these cultures has been su c cessfu lly passaged, so th a t th e fu ll elu cidatio n o f th e virus, and th e antigen w ith w h ich it is in ex trica b ly associated, m ay n o w n ot b e far aw ay ( 19 ) .
DETECTION OF THE ANTIGEN
T h e earlier w orkers e licted the p resen ce of th e A u stralia antigen in serum using th e m icro-O u c h te rlo n y im m u n o d iffu sio n te c h n iq u e (1). S in ce th en , m ore sen sative m eth o d s h ave b e co m e available.
T h e se in clu d e co m p le m e n t fixation , im m u n o ele ctro p h o re sis, haem agglutinatio n , h a em ag g lu tin a tio n -in h ib itio n , radio im m un oassay, and electron m icrosco p y using n egative-stain ing tech niques.
T h e im m u n o d iffu sio n m e th o d is sim p le to perform , b u t n o t sensitive. C o m p le m e n t fixa tio n is m ore sen sitive, and is a m en ab le to q uantitative determ in atio n o f b o th A ustralia a n ti pen and sp ecific a n tib o d y .
Im m u n oeleetroosm oohoresis is a rapid and co m p aratively sim p le tech n iq u e w h ich is less sen sitive than co m p le m e n t fixation b u t m ore sen sitive than im m u n o d iffu sio n .
H aem a gg lu tin a tio n and In cm a eg lu tin a tio n -in h ib itio n are h ig h ly sen sitive fo r d e te ctio n o f a n tib o d y to the antigen.
Electron m icroscopy is relatively elaborate to perform , but is a rapid and sensitive m ethod. Radio-im m unoassay is about twice as sensitive as com plem ent fixation, w hile im m unofluores cence is am enable to detection of the Australia antigen in liver biopsy specim ens.
T h e m ore recently developed m ethods include an im m une adherence-haem agglutination technique which lends itself to autom ation, and a latex agglutination test which is sim ple and rapid to perform , and sensitive.
T h e Australia antigen has been found, not only in serum, but in liver biopsy specim ens, where it can som etim es be dem onstrated by im m unofluorescence when negative in the serum.
Faecal antigens have also been des cribed (20, 28) w hile urinary spread seems probable, for chronic carriers o f the antigen m ay excrete it in their urine.
T h e antigen has also been detected in bile, and m ay well be present in saliva, as scrum hepatitis can apparently be spread b y kissing.
PREVALENCE OF THE ANTIGEN
C o m m u n ity studies have shown that the Australia antigen is rarely found in the healthy p opulation o f N orth Am erica and the U nited Kingdom (0.1 per cent), and is exceptionally rare here in those under 18 .
In tropical coun tries, however, the antigen is found far m ore frequently in the serum of apparently normal people. Figures quoted by B lu m berg (3) for these countries include Costa R icans (2 per cent), Australian aborigines (2.1 per cent), Brazilians (2.5 per cent), M elanesians (3.6 per cent) Filipinos (4.8 per cent), V ietnam ese (6.3 per cent), M icronesians (7.2 per cent), G h a n aians (9.5 per cent), Taiw anese 13 per cent and Peruvian Indians (20.2 per cent).
T h e Australia antigen is also com m only found in patients with acute m yeloid leukae m ia, and with acute and chronic lym phatic leukaem ia.
M o st o f these patients, however, h ave received blood transfusions as part o f their therapy, and few have hepatitis. Patients with leprom atous leprosy also have an unusu ally high incidence of positivity in relation to their fellows in the com m unity and in com parison with patients with tuberculoid leprosy. T h is is presum ably due to their altered cellu lar im m unity, favouring persistence of the antisen , together w ith a high incidence of antigen in the com m unity.
Patients on chronic renal haem odialysis pro gram m es. who also have altered cellular im m unity due to their uraemia, and m ay in addi tion be receiving im m unosuppressive therapy, have an usually high incidence of positivity in com parison w ith other hospitalised patients often becom ing chronic carriers o f the antigen after incidents of m ild hepatitis.
High carriage rates have m ore recently been reported in " m ainline" drug addicts in Europe and A m erica, figures o f 7 per cent being recor ded in one recent survey.
T h e association between Australia antigen and D o w n 's syndrom e has long been recog nised, and was reported b y B lum berg in 19 67 (2) .
Figures of between 27.7 and 35.1 per cent have been variously reported for mongoloid patients in institutions.
M an y of these patients have histological evidence of chronic active hepatitis, and their age at tim e of ex posure seems to determ ine long-term antigen carriage.
T h e chronic carriage of the antigen in these patients m ay also be related to im m unological deficiency.
SERUM HEPATITIS
A lthough B lu m berg and his workers recog nised that the Australia antigen was intim ately associated w ith a virus causing h epatitis and that its presence in serum was indicative of the presence o f that virus (2 1), it was not until later that the clear association o f the Australia antigen with serum or long incubation period hepatitis was shown.
Prince (2 2 ) reported a close association be tween the Australia antigen and lon e incuba tion period hepatitis in 1 968, calling the anti sen S H or serum hepatitis antigen.
It is identical with the Australia antigen and is absent from the serum of patients with com mon source outbreaks of short incubation period infectious hepatitis.
T h e finding of Australia antigen in patients with presumed infectious hepatitis has been reported and is due to the diagnosis being m ade solely on clinical grounds. W h atever one m ay think o f the ethics o f these experim ents -and they certainly provoked a world-wide outcry -the work was brilliantly conceived and m ethodically and scientifically done. B y infecting these children shortly after their admission to the school with serum from patients known to have infective and serum hepatitis and taken from these patients shortly before the developm ent o f jaundice a considerable am ount o f clinical, biochem ical, and other data was collected.
T h e trials were done with the acquiescence of the children's parents and were defended on the grounds that viral hepatitis was endem ic at the school and that the children, m ost of whom could not be toilet trained, would al m ost inevitably acquire hepatitis by the faecaloral route w hile resident in the school.
T h e experim ents were condoned and sanctioned by com m ittees set up in A m erica to m onitor hum an experim entation, and were conducted in accordance with the W o rld M ed ical Associ ation's D raft C o d e o f E th ics o n hum an ex perim entation.
T h e data accum ulated during those studies has contributed im m easurably to the under standing of viral hepatitis.
T w o quite dis tinctive varieties of infectious hepatitis were shown to exist.
O ne type resembled classical infectious hepatitis (IH ) and was characterised by an incubation period of 30-38 days, a rela tively short period o f liver function test abnor m ality and a high degree of infectivity.
T h e second type resem bled serum hepatitis (SH ) and was characterised b y a longer incubation period, a m ore protracted and severe clinical and biochem ical upset and m oderate infectiv ity. O n reinfecting the patients it was shown that one attack of IH protected the child from a second and that patients who had been given the S H type were in no way im m une from the IH variety of infection.
T h e y sub sequently showed also that IH could be trans m itted parenterally as well as orally and SH orally as well as parenterally.
T h e m ode of transmission did not affect the incubation period of the IH virus, this being essentially the same after oral and parenteral exposure. T h e incubation period for the S H virus how ever was longer follow ing oral than parenteral inoculation.
T h e y also showed that gam m a globulin protected against the infectivity of IH but not against that of S H serum.
T h e discovery of the Australia antigen allowed the Krugm an group then to extend their studies using the antigen as a marker. T h e y tested 25,000 specim ens of serum, col lected and stored during their earlier experi m ents on 700 patients with viral hepatitis, for the A ustralia antigen. T h is showed that the Australia antigen was consistently present in se ra from patients with long incubation period hepatitis (SH ) but was not present in sera from patients with short incubation period infective hepatitis (IH ).
M oreover, the anti gen was detected earlier after a parenteral ex posure to S H than to oral exposure, appearing jaundice.
T h e antigen was also found to be two weeks to two m onths before the onset of transient in 65 per cent of the children given S H , lasting a mean of 49 days.
It persisted for m any m onths, however, in the rem aining 35 per cent of children.
In addition, the children given S H infection were im m une fol low ing re-exposure to S H virus one year later. T h e ir observations am ply confirmed that the Australia (hepatitis-associated) antigen was specifically related to serum and not to infec tive hepatitis and showed that if the antigen was present for m ore than four m onths it was likely to persist indefinitely.
T h e y also showed that serum containing the antigen and obtained from patients who had never had overt hepatitis, was capable of causing serum hepatitis.
Indeed, it has been shown that less than 0.001 ml. of serum containing the A ustralia antigen was infectious (25) 
SEOUELAE OF IN F E C T IO N W IT H T H E AU STR ALIA A N T IG E N ( 1) Sources o f Infection
In the clinical context, the classical m ode of infection with the serum hepatitis virus and the Australia antigen is parenteral by the trans fusion o f infected blood or blood products, or by contam inated equipm ent, especially needles or syringes.
T h e increasing incidence of drug abuse ex poses larger num bers of the com m unity to potential syringe-borne infection.
Close con tacts with addicts, who are not themselves " m ainliners" can contract the disease.
It is probable on clinical grounds that kissing and sexual contact with antigen positive persons m ay well lead to serum hepatitis.
It has, of course, also been shown in the W illow brook experim ents that the disease m ay be spread by the faecal-oral route.
Hospital-acquired dis ease, for exam ple in uraemic patients on chronic renal dialysis, m ay also spread to the com m unity.
Indeed, eases have been repor ted where the spouse of such a patient has con tracted a fatal serum hepatitis illness.
T h e im portance o f mass screening o f blood donors is apparent in this context, especially as the antigen has been shown to have persis ted over 20 years in a patient who has remained apparently entirely well over that period (27) . Shaving brushes, razors, toothbrushes, hairdressing implements, dental instruments and tatoo needles contaminated with Australia antigen positive blood have all been implica ted in the spread of serum hepatitis.
T h e identification of the Australia antigen in faeces (28) and urine and bile creates fur ther obvious possible sources for the spread of the disease.
(2) Consequences of Infection
This depends on the dose, virulence of the strain, previous exposure to the antigen, and the immune status of the individual.
In the latter context, depression of cellular immunity is particularly important.
T h e patient who is immunocompetent is likely to get severe or fulminant hepatitis, while the patient who is immunodepressed by disease or iatrogenically is likely to have mild hepatitis.
T he former patient, should he survive, will probably rid himself of the antigen within two months of the onset of clinical hepatitis. T he immunodepressed or immunosuppressed patient is, however, likely to have mild hepa titis with persistence of the antigen, often in definitely.
Some of this group will become apparently healthy long-term carriers of the antigen, while others may develop chronic active hepatitis that may proceed to cirrhosis. This has been well shown in the outbreaks of serum hepatitis in renal dialysis units.
T h e patients tended to have mild hepatitis followed by persistent antigenaemia while the staff had severe and often fatal hepatitis, but cleared the antigen from their blood.
The Australia antigen is detectable in the scrum some weeks before there is subjective or clinical illness and may be detcted in the liver after recovery, when the patient is seronegative. Some antigen positive patients show allergic manifestations during the late incubation period or early in the phase of active hepatitis with urticaria, arthralgia, angioneurotic oede ma and sometimes migrainous headaches. This may be related to the presence of circulating immune complexes of Australia antigen, its antibody, and complement.
The antigen becomes demonstrable in the hepatic parenchymal cells at this stage and can be nicely shown by immunofluorescent or E M studies.
T h e patient may then develop the fulminant picture, which is similar to that of acute massive necrosis from any cause. There is a high mortality rate in this group despite intensive therapy with colomycin, lactulose, parenteral glucose, heparin and fresh frozen plasma followed by extracorporeal perfusion, or exchange transfusion.
M ore often, how ever, the patient will recover after a protracted period of cholestatic jaundice.
M ost who are immunocompetent will clear the antigen with in four to ten weeks (29) .
These are the group, however, who run the risk of destroying their liver, presumably by a vigorous antigenantibody reaction.
M any will have no lasting hepatic damage, although some may proceed to chronic hepatitis of the mild persistent or even the severe aggressive varieties. Chronic persistent hepatitis often follows the classical attack of acute serum hepatitis, leading to cir rhosis, while chronic aggressive hepatitis tends to follow a mild or subclinical attack of antigen positive hepatitis.
Certainly, cirrhosis is most likely when the Australia antigen remains positive after the acute attack.
This persis tent antigenaemia is probably related to im munological defects, especially in cellular im munity.
It is at least possible that the SH virus may gain in virulence by passage through patients who are immunosuppressed either by uraemia or by azathiprine (Imuran), cyclop hosphamide and antilymphocytic serum, causing very severe or fulminant hepatitis when an immunocompetent person is infected. This is, however, conjectural.
CELLULAR IM M UN ITY AND THE ANTIGEN
It has been postulated that a complex series of interactions between the Australia antigen, the serum hepatitis virus and the immune re sponse of the host, both cellular and humoral, follows infection with H A A positive material although immune complexes of H A A and anti body are important in producing some of the varied clinical manifestations that follow infec tion, the cellular immune response seems to de termine the severity and persistence of the as sociated liver damage. It has recently been sug gested that the competence of the cell medi ated (T-lymphocyte dependent) immune sys tem determines whether the infection is selflimiting or persists with varying degrees of damage (30) .
Krugman and his associates showed that in oculation of children with standard prepara tions of Australia antigen-positive scrum re sulted in a spectrum of clinical outcomes (24) . Although transient antigenaemia was usual in association with either overt or anicteric hepa titis, persistence of the antigen could occur in association with either chronic active hepatitis, or w ith out apparent disease. Persis tence o f the antigen is seen frequen tly in patients w ith im paired T -lym p ho cyte function (lym phoproliferative disorders, leprom atous leprosy, chronic lym ph atic leukaem ia).
T h e h igh frequency o f antigen in m ongolism m ay also be related to an abnorm al im m unological status. (30) have suggested that the Australia antigen, on gaining entry to the body, comes into contact w ith susceptible cellspossibly in th e liver.
D u d ley et al
H ere it proliferates, pro ducing further infective particles plus excess virus coat m aterial, both o f which are released from the cell w ith out h aving caused cell nec rosis.
D u rin g transit out o f the liver cell an ti gens specific for the infective agent becom e incorporated in the surface m em brane of in fected cells.
T h e circulating foreign antigens are then recognised b y im m unocom peten t Tlym phocytes which proliferate to produce a num ber o f sensitised lym phocytes.
T h ese then recognise and react w ith th e antigens on the surface o f infected liver cells.
T h is lym ph ocyte/an tigen interaction results in des truction o f th e infective agent, and necrosis o f the liver cell.
M odification of this pattern can explain th e various form s o f Australia anti gen positive liver disease.
It follow s from this postulate that, in the presence o f a norm al im m une response the patient's T -lym p h o cytes w ill react in this m an ner, leading to extensive liver cell necrosisbut with clearance o f the antigen, i.e. the in fective agent.
If all the liver cells are involv ed, severe fulm in an t hepatitis w ill result.
If few cells are infected, the h epatitis w ill be m ild or subclinical.
T h e outcom e, therefore, with norm al im m unological status, is fulm in ant hepatitis, or com plete recovery.
C onversely, if the p atien t's im m unological state is abnor mal, little or no liver dam age w ill result, b ut the p atient would becom e a h ealthy antigenpositive carrier.
A n interm ediate course would likew ise result in a m ild h epatitis fo l lowed by continuing liver cell dam age and per sistent antigenaem ia (30).
It follow s from this hypothesis that im m unosuppression w ill m od ify th e clinical course after HAA infection the therapeutic possibilities o f this being offset by the likelihood o f producing persistent anti genaem ia.
CYTOPLASMIC LOCALISATION OF THE ANTIGEN IN LIVER
R ecen tly, im m unofluorescent and electron m icroscopic techniques have dem onstrated the A ustralia antigen in the cytoplasm of hepatocytes.
H aynes et al (14 ) have shown hepatocytes. in antigen sero-positive patients to contain characteristic particles w ith m em brane bound cytoplasm ic vesicles.
T h e appearances of these particles was sim ilar to that of the A u s tralia antigen particles found in the serum. T w o sizes o f cytoplasm ic particles were obser ved, w ith average diam eters o f 26 and 46 A°. Particles o f both sizes often had a m em brane like outer com ponent and a m oderately elec tron-dense inner com ponent.
T h e y differed in both size and structure from the m ainly intranuclear particles described b y previous authors (3 1).
A lth ough a direct connection betw een the two types o f particles described above has yet to be established, it seem s likely that the diff erent types are related to stages in the develop m ent o f the serum hepatitis virus.
It has been shown that there is apparent intranuclear replication o f 22 A° particles, w ith consider able disruption o f the nucleus, and som etim es also with cytoplasm ic replication, occasionally with the production of rather different parti cles within the cytoplasm ic vesicles.
O thers have shown no intranuclear replication or dam age, but enormous production of particles, within the cytoplasm , o f the larger type -and a m uch greater degree of cytoplasm ic damage. W h eth er these two situations represent differ ent stages of a single process or arc alternative m anifestations of infection b y the S H virus is uncertain.
It seems unlikely, however, that either one could lead directly to the other. A n o th er possibility is that they arc related to the im m unological status of the patient (14) .
CHRONIC ACTIVE HEPATITIS (C.A.H.) AND CIRRHOSIS
T h e rem arkable specificity of the A ustralia antigen for serum hepatitis and chronic active hepatitis in com parison to other form s of liver disease suggests that persistence of the antigen m ay be aetiologically im portant in som e cases of chronic active hepatitis and cirrhosis.
C h ro n ic active hepatitis is characterised by a prolonged course and the presence o f persis tent hepatic inflam m ation with fibrosis which m ay progress to cirrhosis. A ntigen an d /o r antibody to Australia-antigen was also found in 9 out of 10 o f these cases by sensitive im m unological m ethods (34) . T h ese findings remain to be confirm ed, but the suggestion is that the liver dam age in prim ary biliary cirrhosis m ay be due to either continuing replication of the SH virus, or be the result of the p atien t's im m une response to persistent antigenaem ia.
T h e presence of autoim m une (smooth m uscle and anti-m itochondrial) antibodies in this condi tion has led to the suggestion that the condi tion is either due to or associated with abnor m al im m une reactivity, the trigger possibly be ing the S H virus.
HEPATOCELLULAR CARCINOMA AND THE ANTIGEN
T h ere has recently been w orldw ide interest in the possible oncogenic properties of the SH virus and H A A .
In U ganda (35) 40 per cent of patients with hepatocellular carcinoma had the A ustralia antigen in their blood.
T h ese workers found a tendency for H A A positive individuals with hepatocellular carcinoma to be alpha-fetoprotein positive, and to have underlying cirrhosis o f the posthepatic type. Y o u n g patients tended to be H A A positive m ore frequently than the older ones who were often alpha-fetoprotein negative.
T h is data certainly suggests an association between per sistent antigenaem ia and the pathogenesis of hepatom a -at least in Uganda, especially as only 4 of their 12 2 controls (3 per cent) were antigen positive.
It is certainly tem pting to speculate that antecedent viral hepatitis plays a causative role in the neoplastic transformation of the liver cell.
O ther work ers have lent support to this theory, with marked differences across the globe.
In T h e presence o f circulating im m une com plexes in the sera of 3 o f the 4 antigen positive patients was dem onstrated by sero logical, ultraccntrifugal, and E M studies, and were shown to be com posed of Australia anti gen and im m unoglobulin.
Im m unofluorescent studies of tissue from one of the patients revealed deposition o f Australia antigen, Ig M and B 1 C in blood vessel walls.
T h e sugges tion is that the syndrom e o f diffuse vascular damage observed in these patients was due to deposition of im m une com plexes in the blood vessel walls, and that these deposits were com posed o f Australia antigen, hom ologous Ig M antibody, and com plem ent com ponents (37) .
THE HUMAN BEING AND HIS AUSTRALIA ANTIGEN
D uring the recent tragic Edinburgh serum hepatitis outbreak, the com m unity in general and hospital staff in particular cam e face to face with a new and terrifying reality -inocu lation with antigen positive m aterial m ight herald a fatal illness.
T h is transformed people, and created problem s that are only now being fully realised as the im m ediate danger seems past.
Patients were som etim es treated as were lepers, and m any are still aware of being ostracised, despite a long-standing negative Australia antigen.
M an y doctors and nurses did, however, behave in a m anner that does them very great credit, and signs are around that m edicine, in its broadest sense, is com ing to terms with the discovery that Blumberg fell upon quite by accident alm ost a de cade ago.
H e could hardly have realised then that he had, in truth, perhaps created more problem s in his discovery than have been solved by the now clear cut delineation of the two form s of viral hepatitis by the recognition of the Australia antigen. 
